ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference

Core Insights - ProQR Therapeutics N.V. is focused on developing transformative RNA therapies using its proprietary Axiomer™ RNA editing technology platform [1][4] - The company will present at the Citizens Life Sciences Conference on March 11, 2026, at 3:25pm ET [1] - Axiomer technology enables specific single nucleotide changes in RNA, potentially leading to new medicines for various diseases [3][4] Company Overview - ProQR is dedicated to creating RNA therapies that can reverse mutations or modulate protein expression, addressing both rare and prevalent diseases with unmet medical needs [4] - The Axiomer platform utilizes the ADAR (Adenosine Deaminase Acting on RNA) machinery found in human cells to facilitate precise RNA edits [3][4] - The company aims to grow its pipeline with a focus on patient needs and innovative solutions [4]